Business

April 24, 2014 9:38 AM

Quintiles signs major deal with Biogen Idec

Quintiles has inked a partnership with biotechnology company Biogen Idec that one analyst estimates could eventually mean more than $100 million in revenue for the Durham-based pharmaceutical services giant.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs